Banner for leaf pages 2

Darifenacin (Enablex)

Also known as Enablex

Darifenacin (trade name Enablex in US and Canada, Emselex in Europe) is a medication used to treat urinary incontinence. It was discovered by scientists at the Pfizer research site in Sandwich, UK under the identifier UK-88,525 and used to be marketed by Novartis; however in 2010 US rights for were sold to Warner Chilcott for 400 million US$.

Source: Wikipedia

Estimated Total Cost: $124.53 for an average of 28 days supply

What is it prescribed for?

Patients are most commonly prescribed darifenacin to treat involuntary urination, frequent urination, urge incontinence, and benign prostatic hyperplasia (bph).

What side effects are related?

Patients taking darifenacin most commonly experience side effects like constipation, mouth dryness, and headache.

Ajax-loader Loading...